U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
| | | | | | |

U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40

On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…

CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B
| | | | |

CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B

On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…